• Kupffer Cell Plasticity in Liver Metastasis

  2026-09-02

  This study shows that liver metastasis-associated macrophages are maintained not only by recruited monocytes but also by local macrophage proliferation and infiltration of reprogrammed Kupffer cells. Its lineage-tracing and multiomic design clarifies why blocking monocyte-derived macrophages alone may produce limited remodeling of the immunosuppressive metastatic niche.

• MAPK10–KRT16 Signaling Suppresses NSCLC Metastasis

  2026-09-02

  The reference study identifies a phosphorylation-dependent MAPK10/KRT16/RNF213 pathway that limits non-small cell lung cancer metastasis by promoting KRT16 ubiquitination and proteasomal degradation. Its integrated cellular, animal, and clinical evidence supports a mechanistic model for biomarker development while indicating that pathway-specific validation remains necessary before therapeutic translation.

• MK-5108 (VX-689): From AURKA Biology to Assays

  2026-09-01

  MK-5108, also known as VX-689, is a highly selective Aurora A kinase inhibitor for cancer research. This article connects its biochemical selectivity with retinoblastoma evidence and shows how to design more informative cell and xenograft studies without overstating translational conclusions.

• AMG 9810 at the Metabolism–Pain Interface

  2026-09-01

  TRPV1 biology is usually framed through capsaicin, heat, protons, and sensory neuron excitability. A 2024 Autophagy study adds a strategic dimension: metabolic and lysosomal stress can reorganize AMPK–SQSTM1/p62–NFE2L2 signaling through feedback, redox, pH, and calcium-dependent mechanisms. This article explains how AMG 9810 can help translational researchers separate TRPV1-driven sensory signals from stress-adaptive cellular states, while defining the evidence boundaries between pain mechanism research and cancer metabolism.

• 2X Taq PCR Master Mix: From Sample to Symbiont

  2026-08-31

  Learn how 2X Taq PCR Master Mix supports defensible genotyping, cloning, and fungal-symbiont screening. This article connects PCR chemistry with sampling bias, biological validation, and practical assay design.

• Cholecystokinin Octapeptide Ammonium in B-Cell Assays

  2026-08-31

  Cholecystokinin octapeptide ammonium (CCK-8 ammonium) is a sulfated brain–gut peptide with receptor-selective immunomodulatory effects. This article translates the key B-cell evidence into an assay-design framework that separates receptor mechanism, cellular state, and endpoint interpretation.

• Ibuprofen Workflows for Cell and COX Assays

  2026-08-30

  Build more informative Ibuprofen experiments by pairing dual COX inhibition with orthogonal proliferation, apoptosis, and cell-cycle readouts. This workflow also adapts protein-binding concepts from a mubritinib–albumin study without assuming that its findings automatically apply to Ibuprofen.

• Acetylspiramycin in the Resistance Era

  2026-08-29

  Acetylspiramycin, also known as Spiramycin B, is more than a conventional macrolide comparator. Its ribosomal mechanism, activity profile in resistant Mycoplasma pneumoniae isolates, and reported immunomodulatory effects position it as a useful bridge between antimicrobial resistance research and host-pathogen biology. This article outlines how translational teams can deploy the compound in susceptibility testing, mechanistic assays, and decision-oriented research while avoiding overinterpretation of in vitro findings.

• From Superoxide Signal to OA Translation

  2026-08-28

  A mechanistic and strategic guide to using DHE-based intracellular superoxide measurement to validate the PQQ–Nrf2–IGF1R axis in age-related osteoarthritis research and strengthen translational decision-making.

• Allosteric PDK4 Inhibitors for Metabolic Disease

  2026-08-28

  Jeon and colleagues developed a new anthraquinone-derived series of allosteric pyruvate dehydrogenase kinase 4 inhibitors, identifying compound 8c as a potent biochemical inhibitor with activity in metabolic, allergic, and cancer-related preclinical models. The study combines medicinal chemistry, enzyme inhibition, metabolic and pharmacokinetic profiling, animal efficacy testing, and molecular docking to support PDK4 as a tractable therapeutic target while highlighting the evidence still needed for translation.

• 3-Deazaneplanocin (DZNep) Assay Guide

  2026-08-27

  A scenario-based guide to using 3-Deazaneplanocin (DZNep), SKU A1905, in viability, proliferation, apoptosis, and cancer stem cell assays. It connects formulation data, concentration and exposure choices, orthogonal readouts, and vendor-selection criteria to improve interpretation and experimental consistency.

• LEE011 succinate Workflow for CDK4/6 Research

  2026-08-27

  Build more reproducible cancer research workflows with LEE011 succinate, from pH-aware dissolution testing to CDK4/6-driven cell-cycle and proliferation assays. This guide connects formulation behavior, assay design, combination studies, and practical troubleshooting without confusing clinical dose information with in vitro concentration selection.

• MLN4924: NEDD8-Activating Enzyme Inhibitor Workflows

  2026-08-26

  MLN4924 enables controlled neddylation pathway inhibition, making it useful for dissecting CRL-dependent protein degradation, cell-cycle disruption, and cancer-cell death. This workflow-oriented guide also shows how to pair NAE inhibition with time-resolved UV ribotoxic-stress assays without confusing correlation with mechanism.

• Cholesterol in Translational mRNA-LNP Design

  2026-08-26

  Cholesterol is more than a structural lipid in mRNA-LNP development. This thought-leadership guide connects its membrane biology, formulation behavior, and quality attributes with the translational lessons of localized p21 mRNA-LNP therapy for bladder cancer.

• Verbascoside PKC/NF-κB Workflow Guide

  2026-08-25

  Verbascoside provides a practical small-molecule approach for probing PKC/NF-κB control of RANKL-induced osteoclast differentiation and inflammatory signaling. This guide connects concentration-response design, orthogonal pathway readouts, and a carefully bounded extension to trigeminal inflammation research.

8080 records 1/539 page Next 12345 下5页 Last page